United States · FDA National Drug Code directory

Sunitinib malate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63304-093_2971c7ca-50dc-e36c-e063-6294a90a4b7d
Product NDC: 63304-093
Form: CAPSULE
Composition / generic term: Sunitinib malate
Labeler: Sun Pharmaceutical Industries Inc.
Marketing category: ANDA
Marketing start / end (source format): 20191225
Source listing expiry: 20261231

Source-listed ingredients

SUNITINIB MALATE — 37.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

28 CAPSULE in 1 BOTTLE (63304-093-27) · 63304-093-27
4 BLISTER PACK in 1 BOX (63304-093-86) / 7 CAPSULE in 1 BLISTER PACK (63304-093-11) · 63304-093-86

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →